Form 4: Orchestra BioMed CFO Executes Tax Withholding Transaction

CFO Andrew Taylor reported the withholding of 36,352 shares of Orchestra BioMed common stock to satisfy tax obligations related to RSU vesting.

Summary

• Andrew Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc., reported a transaction involving 36,352 shares of common stock.
• The transaction occurred on June 10, 2026, at a price of $4.02 per share.
• The shares were withheld by the company to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following this transaction, the reporting person maintains beneficial ownership of 593,065 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as it reflects standard tax compliance for executive compensation rather than a change in business outlook.

Positives

• The transaction was a mandatory tax withholding event rather than a discretionary open-market sale, indicating continued executive retention of equity.

Negatives

• None identified; this is a routine administrative transaction related to compensation vesting.

Risks

• None identified; this filing pertains to internal tax compliance rather than operational or market risks.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Management Comments

• The filing notes that no shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Industry Context

StockSavvy.ai notes that routine tax withholding filings are standard practice for executives in the biotechnology sector and do not typically signal changes in management sentiment or company performance.

Comparison to Industry Standards

• The transaction follows standard regulatory compliance procedures for equity-based compensation common among publicly traded biotech firms.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-market tax withholding event.

Next Steps

• None indicated.

Key Dates

Keywords

Orchestra BioMed, OBIO, Form 4, Insider Trading, CFO, Tax Withholding, Equity Compensation